eslicarbazepine acetate has been researched along with Behavior Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodie, MJ; Stephen, LJ; Wishart, A | 1 |
| Ahmed, A; Henley, W; Jalihal, V; McLean, BN; Parrett, M; Sander, JW; Shankar, R; Tittensor, P | 1 |
| Assenza, G; Boero, G; Chaves, J; Doherty, CP; McMurray, R; Rheims, S; Villanueva, V | 1 |
| Bridgeman, MB; Dalal, KS | 1 |
4 other study(ies) available for eslicarbazepine acetate and Behavior Disorders
| Article | Year |
|---|---|
Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Fructose; Humans; Lacosamide; Levetiracetam; Male; Medical Audit; Mental Disorders; Middle Aged; Nitriles; Piracetam; Pregabalin; Prospective Studies; Pyridones; Retrospective Studies; Seizures; Sodium Channel Blockers; Topiramate; Young Adult | 2017 |
Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
Topics: Adult; Anticonvulsants; Dibenzazepines; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Humans; Levetiracetam; Male; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Seizures; Substance Withdrawal Syndrome; Treatment Outcome; Voltage-Gated Sodium Channel Blockers | 2018 |
Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Epilepsy; Female; Humans; Intellectual Disability; Male; Mental Disorders; Middle Aged; Treatment Outcome; Young Adult | 2019 |
Neurologic and psychiatric medications.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Cyclopropanes; Dibenzazepines; Drug Therapy; Humans; Mental Disorders; Milnacipran; Nervous System Diseases; Nimodipine | 2015 |